Debio 8206, Pamorelin® 6 * Prostate Cancer, LHRH agonist
Debio 8609, Sanvar®  Esophageal variceal bleeding
Debio 025, HCV Cyclophilin inhibitor
Debio 9902 SR Alzheimer’s, Acetylcholinesterase inhibitor
Debio 0614 Acute heart failure, Luso-inotropic
Debio 0507 Oncology, Platinum micellar nanoparticles
Debio 0719 Oncology, LPA receptors antagonist
Debio 0824 Autoimmune disorders, ShK peptide
Debio 0617 Undisclosed oncology target
Debio 0721 Undisclosed target

* unavailable for out-licensing 

Debiopharm Group's projects cover all molecule type proteins, peptides, small molecules